Homoeopathic potencies of arnica have been used for many years to aid postoperative recovery. The effects of arnica C30 on pain and postoperative recovery after total abdominal hysterectomy were evaluated in a double-blind, randomized, controlled study.
INTRODUCTION
Although there are many documented cases of individual homoeopathic success, there have been few high quality clinical trials of homoeopathy. Kleijnen et al.1 reviewed 107 trials dating back to 1943 . 81 of these studies reported results that favoured homoeopathy and 24 trials found homoeopathy to be ineffective. Considering the low quality of most of these studies, particularly the randomization, Kleijnen et a]. concluded that 'the evidence of clinical trials is positive but not sufficient to draw a definitive conclusion'. It is of note that 15 of 22 of the best designed studies suggested that homoeopathy did have a positive effect.
A review of the published work on arnica reveals that there are nine clinical trials looking at the effects of arnica in trauma; four of these were inconclusive2-5. Arnica in homoeopathic potency has traditionally been utilized by homoeopaths to treat bruising. Campbell6 showed that arnica 10 M was effective in reducing bruising in an experimental pilot study. Arnica C30 appeared ineffective 'Medical Student, 2Medical Statistics and Computing, and 3Department of Medicine, University of Southampton; 4Department of Obstetrics and Gynaecology, Princess Anne Hospital, Southampton, England Correspondence to: Dr George Lewith, University Medicine, Level D (810), Centre Block, Southampton General Hospital, Tremona Road, Southampton S016 6YD, England when compared to placebo. Campbell's trial was not randomized, although a crossover design was employed. All patients received placebo first and arnica second; it may be that the second bruise was not as severe as the first, or perhaps there was some form of accommodation. Furthermore, Campbell's trial size was very small, 13 individuals in the 10 M study and 10 in the 30C study6. In a randomized, double-blind, placebo-controlled crossover study of homoeopathic drugs each prescribed on an individual basis (arnica, hypericum, staphisagria, ledum, phosphorus and plantago at D30 potency) to patients undergoing oral surgery, Lokken et al.7 demonstrated a significant effect from individualized homoeopathy on trismus alone. Trismus was one of only four outcome variables, the others being wound healing, pain and postoperative bleeding. None of the other variables showed a significant change in response to homoeopathy. However, Lokken's study does suggest that appropriately prescribed homoeopathy may have an effect on tissue trauma. Kaziro compared arnica to metronidazole and placebo in reducing post-surgical pain, oedema and wound healing following dental surgery8. Arnica proved significantly less effective than metronidazole. In a similar study Pinsent et al.9 found that arnica C30 could reduce both pain and bleeding in a statistically significant manner after dental extraction, although their statistical analysis is questionable. The study was considered a pilot despite entering 100 patients, 72 of whom completed the trial. The authors themselves felt that there were problems in relation to pain recording, dental anaesthesia, and matching the patients for age and sex. Gibson et al. 10 conducted a small double-blind placebocontrolled trial of arnica in acute trauma patients who were slow to make progress. They reported that those patients receiving arnica C30 showed a significant advantage in both objective and subjective parameters. Differences between the two groups were dramatic, but only 20 Southampton, and then dispensed into individual numbered bottles according to the prearranged randomization code. It was impossible for the investigator or the trial participants to identify whether the tablets were placebo or real treatment. Randomization codes were generated by computer program. Patients were then provided with the next numbered medication bottle from a coded pack on entry into the study.
The choice of homoeopathic potency was a complex one. Pinsent et al., in the largest positive trial involving arnica, used a C30 potency9. Hofmeyr5 used a D6 potency, but that study had fewer patients and the result was not statistically significant. A consensus view was therefore taken among homoeopaths that, along with the clinical trial evidence, led us to choose a 30C potency in this experiment. To measure the efficacy of arnica versus placebo, several outcome measures were employed. Pain and discomfort were measured by standard 1Ocm visual analogue scales completed every 12 h, beginning 12 h after the operation. A maximum of 10 assessments per patient were completed. The length of operation, estimated blood loss and dfficulty of operation were recorded. The surgeon was asked to estimate whether the procedure was easy, difficult or very difficult (1, 2 or 3, respectively). The presence of infection was defined as the clinical need to prescribe antibiotics (over and above prophylaxis). A careful record was kept of the simple analgesics, non-steroidal anti-inflammatories and opioids used in each individual patient. The opioids were provided by patient controlled intravenous infusion (PCA). The primary investigator (OH) assessed the patients' anxiety about their forthcoming procedure at entry into the study. This was a simple clinical observation; patients rated one star were very anxious and those rated three appeared very relaxed about the procedure. After hospital discharge, each patient was followed up by telephone 2 weeks after the procedure and asked if she had any residual pain, difficulty or complication as a result of the hysterectomy.
Statistical comparisons between the groups were performed by Mann-Whitney U tests, chi-square tests and ANCOVA (analysis of covariance). Adjusted means were computed by general factorial analysis of variance. Comparisons between the two groups of pain scores over time were made by computing summary measures, such as rate and the area under the curve, as described by Matthews et al. 13 The data were analysed by use of SPSS for Windows (version 6.1)14. Data were analysed blindly with respect to treatment allocation.
RESULTS
Of the 93 women recruited into the study, 20 did not complete protocol treatment. Of these, nine were excluded because they failed to comply (i.e. did not take their medication as directed), nine had their operations cancelled 
Analgesics
The arnica patients had higher total opioid and temazepam intake but lower antiemetic doses; none of these differences was statistically significant ( Table 2) . Analysis of covariance, adjusting for age, estimated blood loss and length of operation also revealed no statistically significant differences in analgesic intake between the groups. Time of assessment (12 h Intervals) Figure 2 Ten individual plots (five from each group) picked at random to demonstrate the variety of pain score against time after operation, observed for the 73 patients in the study. In terms of pain, analgesia, infection and operative severity, this study revealed no significant differences between the arnica and placebo groups. The arnica group were slightly younger and had longer operations than the placebo group. These differences, coupled with the higher initial pain scores in the arnica patients, might have contributed to the marginally faster rate of recovery in the arnica group. Posthoc analysis of covariance, excluding the initial pain scores from the calculation of the regression slopes, was performed to explore the influence of the initial pain scores on the rate of improvement in pain. Exclusion of just the first pain score had little effect on the adjusted mean, but exclusion of the first and second scores reduced the adjusted mean difference to -0.08 (95% CI =-0.23 to 0.07, P= 0.30). Whilst the unadjusted analysis favours the placebo group for mean pain score and area under the curve, the analysis of covariance indicates that the two groups are comparable.
Pinsent et al. 9 , who reported the only positive study, freely admit that their methodology and statistics were flawed, and that their pain recording and follow-up were inadequate. Our study entered a relatively large number of patients, all of whom were followed up scrupulously. The groups are well balanced for most entry criteria other than age. Only the placebo group has patients over 55 years of age and these patients tended to have lower initial visual analogue scores. Those below 55 years had a greater spread (both high and low) of their initial visual analogue score. In future studies involving postoperative pain we recommend stratification by age to ensure that the groups are evenly balanced. One possibility, though less likely, is that the higher initial pain scores represent homoeopathic aggravation. When an individual displays such aggravations homoeopaths consider this represents a healing crisis which ultimately results in dramatic improvement. However, since we were unable to measure pain before the operation, we can do no more than hypothesize about the possibility of an aggravation. Since the two groups showed similar trends during their stay at hospital and at two weeks' follow-up, the concept of healing crisis would appear to have little substance in relation to overall outcome.
The study by Lokken et al.7 is particularly fascinating.
The summary of the paper indicates that homoeopathy had no benefit in dental pain, but closer analysis reveals less trismus in the homoeopathically treated group than in the placebo group. Wound healing and pain did not differ. It does seem that, in this study, arnica may have had an effect on tissue trauma as reflected in trismus. This notion is in accord with the homoeopathic indications for arnica as well as Campbell's work on bruising6; so future studies should focus more on tissue trauma and bruising than on pain and wound healing. Furthermore, routine analgesia may have masked any effect provided by arnica. If this is the case then the overall effects of arnica in the context of operative intervention are probably very small and certainly do not justify the introduction of arnica as a routine preoperative preparation or postoperative treatment.
The arnica dosage regimen may have been less than ideal. We have already outlined our reasons for choosing 30C arnica, but fully accept that the choice of potency in this study is based on limited information. Pinsent et a]. used arnica only after the operative intervention; their regimen provided arnica 30C every 15 min for the first 45 min postoperatively (three doses) and thereafter 2-hourly for the next six doses9. We were unable to effect this dosage regimen and indeed believe it would be impractical in most situations after major surgery.
Almost all patients undergoing hysterectomy complained of postoperative 'wind pain'. Arnica is intended to relieve the pain and bruising that results from trauma, and any beneficial effects on the wound itself might have been masked by the patient's generalized postoperative abdominal discomfort. However, we would again argue that if arnica was having an effect, in the context of this operative intervention, its effect is marginal.
